- E26.09 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E26.09 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E26.09 – other international versions of ICD-10 E26.09 may differ.
ICD-10-CM E26.09 is grouped within Diagnostic Related Group(s):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Applicable To
- Primary aldosteronism due to adrenal hyperplasia (bilateral)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E26.09:
- primary (due to (bilateral) adrenal hyperplasia) > Aldosteronism E26.9
- primary NEC > Aldosteronism E26.9
- primary (due to (bilateral) adrenal hyperplasia) > Hyperaldosteronism E26.9
- primary NEC > Hyperaldosteronism E26.9